Unlocking the Potential of GLP-1s to Treat Addiction & Substance Use Disorders to Reduce Cravings & Impulsivity to Provide a Novel Treatment Option

• Modulating brain reward circuits to reduce cravings and impulsivity, offering a novel, non-addictive therapeutic option for substance use disorders
• Expanding the therapeutic scope of GLP-1s to offer a new treatment for addiction to help address a major public health crisis with a new mechanism
• Integrating GLP-1 therapy with behavioural interventions to enhance treatment efficacy, leading to better patient outcomes and a higher rate of long-term recovery

Speakers:

Ashwani Singal

Professor of Medicine

University of Louisville